» Articles » PMID: 19033732

Prevalence of Self-reported Allergic Rhinitis in Eleven Major Cities in China

Overview
Date 2008 Nov 27
PMID 19033732
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Allergic rhinitis (AR) is a common disease and its prevalence is increasing worldwide. Data on the current prevalence of AR in China, one of the biggest countries in the world, with a population of around 1.3 billion citizens, are scarce. The aim of this study was to investigate the prevalence of self-reported AR in Chinese citizens.

Methods: In a cross-sectional, population-based study, telephone interviews were conducted in 11 major cities in China after sampling target telephone numbers through the approach of random digital dialing. The questions for the telephone interviews were based on validated questionnaires.

Results: A total of 38,203 telephone interviews were conducted from September 2004 to May 2005. The response rate was 63.7%. After adjustment for age and gender, the self-reported prevalence of AR was lowest in Beijing (8.7%) and highest in Urumqi (24.1%). Among the subjects with self-reported AR, 25.6% were diagnosed with persistent AR and 74.4% suffered from intermittent AR. Less than half of the subjects with self-reported AR had presented at a health clinic. In 37.3% AR had previously been diagnosed by physicians, and 33.1% of subjects with self-reported AR had been treated. Comorbidities reported were asthma (9.2%), rhinosinusitis (13.3%) and atopic dermatitis (16.4%).

Conclusions: This study demonstrates that the self-reported prevalence of AR in 11 cities across Mainland China has wide variations, ranging from <10% to >20%; 26% of the self-reported AR subjects were classified as suffering from persistent AR.

Citing Articles

ITS and 16S rRNA Gene Revealed Multitudinous Microbial Contaminations of Residential Air Conditioning Filters in Megacity Shanghai, China.

Geng X, Nie C, Wang L, Li L, Li D, Nishino A Environ Health (Wash). 2024; 2(1):34-41.

PMID: 39473487 PMC: 11503804. DOI: 10.1021/envhealth.3c00145.


A single-dose, randomized, open-label, four-period, crossover equivalence trial comparing the clinical similarity of the proposed biosimilar rupatadine fumarate to reference Wystamm in healthy Chinese subjects.

Lin S, Lou Y, Hao R, Shao Y, Yu J, Fang L Front Pharmacol. 2024; 15:1328142.

PMID: 38828454 PMC: 11140027. DOI: 10.3389/fphar.2024.1328142.


Research progress of traditional Chinese medicine in the treatment of allergic rhinitis.

Yue J, Hao D, Liu S, Yu J, Meng L, Lv J Heliyon. 2024; 10(7):e29262.

PMID: 38617960 PMC: 11015441. DOI: 10.1016/j.heliyon.2024.e29262.


The Assessment of Gene Polymorphism Association with the Risk of Allergic Rhinitis in the Chinese Han Population from Northern China.

Han H, Lian P, Chen H, Shamsi B, Liu Y, Niu Y J Asthma Allergy. 2023; 16:979-986.

PMID: 37745900 PMC: 10516186. DOI: 10.2147/JAA.S421939.


Prevalence of allergen sensitization among children with allergic rhinitis in Changzhou, China: a retrospective observational study.

Hu Z, Xue J, Pan M, Bao Y, Zou W, Wang C BMC Pediatr. 2023; 23(1):466.

PMID: 37716964 PMC: 10504732. DOI: 10.1186/s12887-023-04291-9.